Facebook User Plaintiffs and Defendant Facebook have agreed to resolve In re: Facebook, Inc. Consumer Privacy User Profile Litig., No. 3:18-md-02843-VC, the class action arising out of the Cambridge Analytica scandal, for $725 million—the ...
Keller Rohrback is pleased to announce that on December 15, 2022, Monsanto Company has agreed to pay $698 million to the State of Oregon to resolve the State’s claims against the giant multinational chemical company for PCB contamination ...
The Keller Rohrback ERISA team, along with co-counsel at Stris & Maher and the Seattle City Attorney, completed its successful defense of a landmark Seattle ordinance when the Supreme Court denied a petition for certiorari brought by a ...
Keller Rohrback is honored to have been included in the 2023 edition of the U.S. News & World Report’s– Best Lawyers® "Best Law Firms" publication receiving multiple tiered rankings in various recognized practice ...
Keller Rohrback partner, Derek Loeser has recently been featured in the popular Lawdragon.com Lawyer Limelight interview series. In his interview, Derek discusses his early career working for the US Department of Justice in the Civil Rights ...
Keller Rohrback is investigating the high price of Nuvigil (generically known as armodafinil). Nuvigil is a critical medication used to reduce extreme sleepiness in sufferers of narcolepsy and other sleep-related disorders.
Congratulations to Keller Rohrback partner Jeff Liang, on being selected to receive the National Asian Pacific Bar Association (NAPABA) 2022 Pro Bono Service Award! This award recognizes an attorney or team of attorneys for outstanding ...
Keller Rohrback is honored to have been recognized by the American Antitrust Institute (AAI) for its work on the In re EpiPen Marketing, Sales Practices, and Antitrust Litigation. The Keller Rohrback team of Lynn Sarko, Gretchen Freeman ...
